REG - Cerillion PLC - Appointment of Joint Broker

CerillionAnnouncement

06/10/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221006:nRSF8881Ba&default-theme=true

RNS Number : 8881B  Cerillion PLC  06 October 2022

AIM: CER

Cerillion plc

("Cerillion" or "Company" or "Group")

Appointment of Joint Broker

 

Cerillion, the billing, charging and customer relationship management software
solutions provider, announces the appointment with immediate effect of Singer
Capital Markets as the Company's joint broker, alongside Liberum Capital
Limited ("Liberum"), the Company's nominated adviser and joint broker.

 

For further information please contact:

 Cerillion plc                                  c/o KTZ Communications

 Louis Hall, CEO, Andrew Dickson, CFO           T: 020 3178 6378

 Liberum (Nomad and Joint Broker)               T: 020 3100 2000
 Bidhi Bhoma, Cameron Duncan, William Hall

 Singer Capital Markets (Joint Broker)          T: 020 7496 3000
 Rick Thompson, George Tzimas, James Fischer

 KTZ Communications                             T: 020 3178 6378
 Katie Tzouliadis, Dan Mahoney

 

About Cerillion

www.cerillion.com

Cerillion is a leading provider of mission critical software for billing,
charging and customer relationship management ("CRM"), mainly serving the
telecommunications market but also other sectors such as utilities and
financial services. The Company currently has c.80 customer installations
across c.44 countries. Headquartered in London, Cerillion also has operations
in India, Bulgaria and Australia.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPMABLTMTIMMRT